Form 4: Kenvue General Counsel Receives Stock Award

Kenvue Inc.'s General Counsel, Matthew Orlando, was granted 122,286 Restricted Stock Units vesting over three years.

Summary

• Matthew Orlando, General Counsel of Kenvue Inc., was granted 122,286 Restricted Stock Units (RSUs).
• The RSUs correspond on a one-for-one basis with the company's common stock.
• The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029.
• Vesting is contingent upon Mr. Orlando's continued service to the company through each vesting date.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices aimed at retaining key talent and aligning management incentives with shareholder interests.

Positives

• The grant of Restricted Stock Units to General Counsel Matthew Orlando aligns his interests with those of shareholders, promoting long-term retention and performance.
• The vesting schedule over three years provides an incentive for continued service and stability in a key leadership role.

Risks

• The vesting of the Restricted Stock Units is subject to the reporting person's continued service, meaning the award could be forfeited if employment ceases before vesting dates.

Future Outlook

The future outlook indicates that Matthew Orlando will receive shares of Kenvue common stock in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, provided he remains employed by the company.

Industry Context

StockSavvy.ai notes that the grant of equity awards like Restricted Stock Units is a standard practice in executive compensation across various industries, particularly in consumer health and pharmaceutical sectors, to attract, retain, and incentivize key personnel. This aligns executive interests with long-term shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units with a multi-year vesting schedule is a common compensation tool, comparable to practices at peer companies in the consumer health sector such as Procter & Gamble (PG), Johnson & Johnson (JNJ), and Colgate-Palmolive (CL), which frequently utilize similar long-term incentive plans for their executives to foster retention and performance alignment.

Related Party Transactions

• The grant of 122,286 Restricted Stock Units to Matthew Orlando, General Counsel, constitutes a related party transaction as it involves compensation to an executive officer.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns the General Counsel's long-term interests with shareholder value creation.
• Employees: This type of compensation can signal stability in leadership and a commitment to retaining key talent.

Next Steps

• First RSU vesting installment on March 2, 2027.
• Second RSU vesting installment on March 2, 2028.
• Third RSU vesting installment on March 2, 2029.

Key Dates

Keywords

Kenvue, KVUE, Matthew Orlando, General Counsel, Restricted Stock Units, RSU, stock award, insider transaction, executive compensation, beneficial ownership